"TEM1 is over-expressed in a variety of tumors," says Coukos, including breast cancer, colon cancer and glioblastoma. They also found that all 52 samples of ovarian cancer contained TEM1 in the blood vessels, compared with none of the healthy tissue samples. "There have been a number of studies which show that women with ovarian cancer, if they are operated on by a gynecologic cancer specialist, have a substantially better outcome than women who don't," she says. They found that high levels of TEM1 were linked to decreased survival in ovarian cancer patients. -- Researchers at the University of Pennsylvania have zeroed in on a possible marker for ovarian cancer.